Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty

NCT: NCT02836262 · RECRUITING

NCT IDNCT02836262
StatusRECRUITING
Start Date2017-08-25
Completion2032-09-16
SponsorHip Innovation Technology (INDUSTRY)
First posted
Last updated

Brief Summary

To evaluate effectiveness and safety of HHRS in subjects undergoing total hip arthroplasty (THA). Effectiveness will be evaluated using patient-reported, clinical, radiologic, and radiostereometric outcomes. Safety will be evaluated through the collection of device-related and unanticipated device-related adverse events.

Frequently Asked Questions

What is Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty?

Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty is a clinical trial registered under NCT02836262. Current status: RECRUITING.

What is the status of NCT02836262?

The current status of NCT02836262 (Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty) is: RECRUITING.

When did Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty start?

Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty started on 2017-08-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑